Research & Education
CURE Expert Connections
Email Sign Up
To start your customized experience click the start button
Customize your homepage by selecting specific cancer types.
Cancer of Unknown Primary
Diet and Exercise
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
Mantle Cell Lymphoma
Metastatic Breast Cancer
Side Effect Management
Small Lymphocytic Lymphoma (SLL)
Advocacy & Research
Share Your Story
Newsletter Sign Up
Ovarian Cancer Heroes
Bone Health Champions
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Cranbury, NJ 08512
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
The Typical Prognosis of Aggressive Renal Cell Cancer
Steven Gallant discusses his current status, regarding the treatment journey, with his oncologist Karl J. D’Silva.
Despite Advantages, Disparities in Access to Palliative Care in Kidney Cancer Remain
Although palliative care has been shown to improve survival rates among patients with metastatic renal cell carcinoma, its utilization remains low while certain barriers and disparities still exist.
Novel 'Theranostic' Screening Tool Shows Promise in Determining Kidney Cancer Treatment
Kristie L. Kahl
A novel imaging test developed at UT Southwestern may help to determine which patients with kidney cancer would benefit from treatment with immunotherapy.
Survey Results Highlight Unmet Needs of Patients with Kidney Cancer Worldwide
An international study of nearly 2,000 patients with renal cell carcinoma exposed many unmet needs across all stages of disease.
Immunotherapy Combinations Transform Renal Cell Carcinoma Treatment
Patients with advanced renal cell carcinoma have new first-line therapy options.
FDA Approves Bavencio-Inlyta Combo for Advanced Renal Cell Carcinoma
Kristie L. Kahl
The Food and Drug Administration approved the combination use of Bavencio plus Inlyta for the first-line treatment of patients with advanced renal cell carcinoma.
Yervoy Plus Opdivo Appears to be a Cost-Effective Treatment Option in Kidney Cancer
Kristie L. Kahl
With the growing price of cancer treatment, researchers evaluated the cost-effectiveness of the new standard-of-care in frontline metastatic renal cell carcinoma.
Findings Confirm Exercise Benefit for Kidney Cancer Survivors
Kidney cancer survivors who follow recommendations for physical activity experience improved quality of life, but few individuals adhere to the guidelines, according to recent findings.
Immunotherapy Combinations Show Promise in Frontline Setting for Advanced Kidney Cancer
With patient resistance to single-agent immunotherapies in the treatment of advanced renal cell carcinoma, new combination therapies are needed in the frontline setting.
The Role of Mental Health in Cancer Outcomes
A person’s pre-existing mental state may negatively influence their health, but professional support can help maintain the best mindset, say researchers.
Not a member?
Sign up now!
Continue without login
OPTIONAL INFORMATION: The following information helps us tailor CURE to fit your needs
Please type below what best describes your interests and click on the selection(s):
I am a:
Please list other: